Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 1/2009

Open Access 01-12-2009 | Review

Complexity, cofactors, and the failure of AIDS policy in Africa

Author: Eileen Stillwaggon

Published in: Journal of the International AIDS Society | Issue 1/2009

Login to get access

Abstract

Global AIDS policy still treats HIV as an exceptional case, abstracting from the context in which infection occurs. Policy is based on a simplistic theory of HIV causation, and evaluated using outdated tools of health economics. Recent calls for a health systems strategy – preventing and treating HIV within a programme of comprehensive health care – have not yet influenced the silo approach of AIDS policy.
Evidence continues to accumulate, showing that multiple factors, such as malnutrition, malaria and helminthes, increase the risk of sexual and vertical transmission of HIV. Moreover, complementary interventions that reduce viral load, improve immune response, and interrupt pathways of transmission could increase the effectiveness of antiretroviral drugs and other tools of AIDS policy.
In health economics, the omission of estimates of increasing returns generated by disease or treatment synergies biases cost-effectiveness analysis against multiple, yet inexpensive, interventions. Current tools of cost-effectiveness analysis only identify local maxima in a complex landscape, and can play, at best, a marginal role in the epidemic, especially where it is already generalized.
Cost-effectiveness analyses for HIV that are based on the wrong epidemiological model can generate Type III errors: we get precise answers to the wrong questions about how to intervene. To control the epidemic, AIDS policy needs to utilize an epidemiological model that reflects the interactions of biological as well as behavioural variables that determine the course of HIV epidemics around the world. Cost-effectiveness analysis can benefit from using economic concepts of externalities and increasing returns to incorporate disease interactions and beneficial treatment spillovers for coinfections in HIV-prevention policy.
Literature
1.
Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N: Sexual Behaviour in Context: a Global Perspective. Lancet 2006, 368: 1706–1728.CrossRefPubMed
2.
Singh S, Darroch JE: Trends in Sexual Activity among Adolescent American Women: 1982–1995. Family Planning Perspectives 1999, 31: 212–219.CrossRefPubMed
3.
Reinisch JM, Sanders SA, Hill CA, Ziemba-Davis M: High-risk Sexual Behavior among Heterosexual Undergraduates at a Midwestern University. Family Planning Perspectives 1992, 24: 116–121. 145CrossRefPubMed
4.
Smith TW: Adult Sexual Behavior in 1989: Number of Partners, Frequency of Intercourse and Risk of AIDS. Family Planning Perspectives 1991, 23: 102–107.CrossRefPubMed
5.
Stillwaggon E: AIDS and the Ecology of Poverty. New York: Oxford University Press; 2006.
6.
MacDonald NE, Wells GA, Fisher WA, Warren WK, King MA, Doherty JA, Bowie WR: High-risk STD/HIV Behavior among College Students. Journal of the American Medical Association 1990, 263: 3155–3159.CrossRefPubMed
7.
Kost K, Forrest JD: American Women's Sexual Behavior and Exposure to Risk of Sexually Transmitted Diseases. Family Planning Perspectives 1992, 24: 244–254.CrossRefPubMed
8.
Turner R: Landmark French and British Studies Examine Sexual Behavior, Including Multiple Partners, Homosexuality. Family Planning Perspectives 1993, 25: 91–92.CrossRef
9.
Billy JOG, Tanfer K, Grady WR, Klepinger DH: The Sexual Behavior of Men in the United States. Family Planning Perspectives 1993, 25: 52–60.CrossRefPubMed
10.
Grinstead O, Faigeles B, Binson D, Eversley R: Sexual Risk for Human Immunodeficiency Virus Infection among Women in High-risk Cities. Family Planning Perspectives 1993, 25: 252–256.CrossRefPubMed
11.
Singh S, Wulf D, Samara R, Cuca Y: Gender Differences in the Timing of First Intercourse: Data from 14 Countries. International Family Planning Perspectives 2000, 26: 21–28.CrossRef
12.
Epstein H: The Invisible Cure. New York: Farrar, Strauss and Giroux; 2007.
13.
Kretzschmar M, Morris M: Measures of Concurrency in Networks and the Spread of Infectious Disease. Math Biosci 1996, 133: 165–195.CrossRefPubMed
14.
Mishra V, Bignami-Van Assche S: Concurrent Sexual Partnerships and HIV Infection: Evidence from National Population-Based Surveys. DHS Working paper: USAID; 2009.
15.
16.
Cleland J, Ferry B, Caraël M: Summary and Conclusions. In Sexual Behaviour and AIDS in the Developing World. Edited by: Cleland J, Ferry B. London: Taylor and Francis for the World Health Organization; 1995:208–228.
17.
World Bank: Confronting AIDS: Public Priorities in a Global Epidemic. Oxford: Oxford University Press; 1997.
18.
Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, et al.: Impact of Improved Treatment of Sexually Transmitted Diseases on HIV Infection in rural Tanzania: Randomised Controlled Trial. Lancet 1995, 346: 530–536.CrossRefPubMed
19.
Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al.: Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999, 353: 525–535.CrossRefPubMed
20.
Auvert B, Males S, Puren A, Taljaard D, Carael M, Williams B: Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr 2004, 36: 613–621.CrossRefPubMed
21.
22.
Pelletier DL, Frongillo EA, Schroeder DG, Habicht JP: The Effects of Malnutrition on Child Mortality in Developing Countries. Bulletin of the World Health Organization 1995, 73: 443–448.PubMed
23.
Friis H, Michaelsen KF: Micronutrients and HIV Infections: A Review. European Journal of Clinical Nutrition 1998, 52: 157–163.CrossRefPubMed
24.
Chandra RK: Nutrition and the immune system: an introduction. American Journal of Clinical Nutrition 1997, 66: 460S-463S.PubMed
25.
Beisel W: Nutrition and Immune Function: Overview. Journal of Nutrition 1996, 126: 2611S-2115S.PubMed
26.
Fawzi WW, Hunter DJ: Vitamins in HIV disease progression and vertical transmission. Epidemiology 1998, 9: 457–466.CrossRefPubMed
27.
John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, et al.: Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. Journal of Infectious Diseases 1997, 175: 57–62.PubMed
28.
Landers D: Nutrition and Immune Function II: Maternal Factors Influencing Transmission. Journal of Nutrition 1996, 126: 2637S-2640S.PubMed
29.
Nimmagadda A, O'Brien W, Goetz M: The Significance of Vitamin A and Carotenoid Status in Persons Infected by the Human Immunodeficiency Virus. Clinical Infectious Diseases 1998, 26: 711–718.CrossRefPubMed
30.
Semba R, Miotti P, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR: Maternal Vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994, 343: 1593–1597.CrossRefPubMed
31.
32.
Abu-Raddad L, Patnaik P, Kublin JG: Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa. Science 2006, 314: 1603–1606.CrossRefPubMed
33.
Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al.: Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000, 356: 1051–1056.CrossRefPubMed
34.
Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A, Hayes RJ: HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 2002, 359: 2177–2187.CrossRefPubMed
35.
Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG: Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995, 9: 721–726.CrossRefPubMed
36.
Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al.: The Effect of plasmodium falciparum Malaria on HIV-1 RNA Blood Plasma Concentration. AIDS 1999, 13: 487–494.CrossRefPubMed
37.
Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA: Plasmodium falciparum Antigen-Induced Human Immunodeficiency Virus Type 1 Replication Is Mediated through Induction of Tumor Necrosis Factor-alpha. Journal of Infectious Diseases 1998, 177: 437–445.CrossRefPubMed
38.
39.
40.
Wolday D, Mayaan S, Mariam ZG, Berhe N, Seboxa T, Britton S, et al.: Treatment of Intestinal Worms Is Associated with Decreased HIV Plasma Viral Load. Journal of Acquired Immune Deficiency Syndromes 2002, 31: 56–62.PubMed
41.
Montresor A, Ramsan M, Chwaya HM, Ameir H, Foum A, Albonico M, et al.: Extending Anthelminthic Coverage to Non-enrolled School-Age Children Using a Simple and Low-Cost Method. Tropical Medicine and International Health 2001, 6: 535–537.CrossRefPubMed
42.
Borkow G, Bentwich Z: HIV and Helminth Coinfection: Is Deworming Necessary? Parasite Immunology 2006, 28: 605–612.PubMed
43.
Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB: Filarial Infections Increase Susceptibility to Human Immunodeficiency Virus Infection in Peripheral Blood Mononuclear Cells In Vitro. Journal of Infectious Diseases 2000, 182: 1804–1808.CrossRefPubMed
44.
Nacher M: Worms and Malaria: Noisy Nuisances and Silent Benefits. Parasite Immunology 2002, 24: 391–393.CrossRefPubMed
45.
Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, et al.: Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 2008, 22: 1601–1609.CrossRefPubMed
46.
47.
Marble M, Key K: Clinical Facets of a Disease Neglected Too Long. AIDS Weekly Plus 1995, 16–19.
48.
Feldmeier H, Poggensee G, Krantz I, Helling-Giese G: Female Genital Schistosomiasis. New Challenges from a Gender Perspective. Trop Geogr Med. 1995, 47 (2 Suppl) : S2-S15.PubMed
49.
Attili VR, Hira S, Dube MK: Schistosomal Genital Granulomas: A Report of 10 Cases. British Journal of Venereal Disease 1983, 59: 269–272.
50.
Leutscher P, Ravaoalimalala VE, Raharisolo C, Ramarokoto CE, Rasendramino M, Raobelison A, et al.: Clinical Findings in Female Genital Schistosomiasis in Madagascar. Trop Med Int Health. 1998, 3 (4) : 327–332.CrossRefPubMed
51.
Kjetland E, Ndhlovu P, Gomo E, Mduluza T, Midzi N, Gwanzura L, Mason PR, Sandvik L, Friis H, Gundersen SG: Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006, 20: 593–600.CrossRefPubMed
52.
Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al.: Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. New England Journal of Medicine 2000, 342: 921–929.CrossRefPubMed
53.
Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA, Quebec Primary HIV Infection Study Group: High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection. Journal of Infectious Diseases 2007, 195: 951–959.CrossRefPubMed
54.
Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al.: Effect of Plasmodium falciparum Malaria on Concentration of HIV-1-RNA in the Blood of Adults in Rural Malawi: A Prospective Cohort Ctudy. Lancet 2005, 365: 233–240.PubMed
55.
Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA: Cost Effectiveness Analysis of Strategies to Combat HIV/AIDS in Developing Countries. BMJ 2005, 331: 1431–1437.CrossRefPubMed
56.
Schwartlander B, Stover J, Walker N, Bollinger L, Gutierrez JP, McGreevey W, et al.: AIDS. Resource needs for HIV/AIDS. Science 2001, 292: 2434–2436.CrossRefPubMed
57.
Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, et al.: Can We Reverse the HIV/AIDS Pandemic with an Expanded Response? Lancet 2002, 360: 73–77.CrossRefPubMed
58.
Stillwaggon E: Race, Sex, and the Neglected Risks for Women and Girls. Feminist Economics 2008, 14: 67–86.CrossRef
59.
van Vliet C, Holmes K, Singer B, Habbema JD: The Effectiveness of HIV Prevention Strategies under Alternative Scenarios: Evaluation with the STDSIM Model. In Confronting AIDS: Evidence from the Developing World. Selected Background Papers for the World Bank Policy Research Report, Confronting AIDS: Public Priorities in a Global Epidemic. Edited by: Ainsworth M, Fransen L, Over M. Brussels and Washington, D.C: European Commission and World Bank; 1998:207–238.
60.
61.
62.
Orroth KK, Freeman EE, Bakker R, Buve A, Glynn JR, Boily MC, et al.: Understanding the Differences between Contrasting HIV Epidemics in East and West Africa: Results from a Simulation Model of the Four Cities Study. Sexually Transmitted Infections 2007, 83 (Supplement 1) : i5–16.CrossRefPubMed
63.
Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, et al.: Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001, 17: 901–910.CrossRefPubMed
64.
65.
Gisselquist D, Potterat JJ, Brody S, Vachon F: Let it be sexual: How health care transmission of AIDS in Africa was ignored. Int J STD AIDS. 2003, 14 (3) : 148–161.CrossRefPubMed
66.
Gisselquist D, Potterat JJ, Brody S: HIV Transmission during Paediatric Health Care in Sub-Saharan Africa-Risks and Evidence. South African Medical Journal 2004, 94: 109–116.PubMed
67.
Bird RJ: Chaos and Life: Complexity and Order in Evolution and Thought. New York: Columbia University Press; 2003.
68.
69.
70.
71.
Kauffman SA: The Origins of Order: Self-Organization and Selection in Evolution. New York: Oxford University Press; 1993.
72.
Henderson J: Health Economics and Policy. Cincinnati: South-Western College Publishing; 1999.
73.
Chesson HW, Pinkerton SD: Sexually Transmitted Diseases and the Increased Risk for HIV Transmission: Implications for Cost-effectiveness Analyses of Sexually Transmitted Disease Prevention Interventions. J Acquir Immune Defic Syndr. 2000, 24 (1) : 48–56.PubMed
74.
Arthur BW: Competing Technologies, Increasing Returns, and Lock-In by Historical Events. Economic Journal 1989, 99: 116–131.CrossRef
75.
Romer P: Increasing Returns and Long-Run Growth. Journal of Political Economy 1986, 94: 1002–1037.CrossRef
76.
Romer P: Endogenous Technological Change. Journal of Political Economy 1990, 98: S71-S102.CrossRef
77.
Romer P: The Origins of Endogenous Growth. Journal of Economic Perspectives. 1994, 8: 3–22.
78.
Schwartz S, Carpenter K: The Right Answer for the Wrong Question: Consequences of Type III Error for Public Health Research. American Journal of Public Health 1999, 89: 1175–1179.CrossRefPubMed
79.
Miguel EA, Kremer M: Worms: Education and Health Expenditures in Kenya. In NBER Working Papers. Cambridge, Mass: National Bureau of Economic Research; 2001.
Metadata
Title
Complexity, cofactors, and the failure of AIDS policy in Africa
Author
Eileen Stillwaggon
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2009
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-12-12

Other articles of this Issue 1/2009

Journal of the International AIDS Society 1/2009 Go to the issue

Review

The fields of HIV and disability: past, present and future

Research

Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens

Meeting report

Meeting report of the International Policy Dialogue on HIV/AIDS and Disability

Research

HIV/AIDS, growth and poverty in KwaZulu-Natal and South Africa: an integrated survey, demographic and economy-wide analysis

Research

From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania

Editorial

Special theme on HIV and disability - time for closer bonds
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits